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Osteoarthritis (OA)
Ashley D. Smith, BSN RN
Otterbein University, Westerville, Ohio
Underlying
Pathophysiology

Signs & Symptoms
•

Joint pain: usually starts sharp, as
OA progresses becomes dull and
achy

•

Stiffness: worse in the AM or after
prolonged inactivity

•
•

Joint or bone inflammation
Reduced range of motion: joint
impairment, typically reported as
joint inflexibility

•
•

Tenderness: to area around
inflamed joint

Increasing age: most common risk
factor for OA
Gender: female sex

•

Race: African-Americans,
especially in symptomatic hip and
knee OA

•

•

•

•

•

•

•

Synovitis: can develop as OA
progresses

Risk Factors
•

•

•

•

Obesity: poor dietary choices,
inactivity, lifestyle
Injury: sports or occupational
risks, history of trauma to joint;
frequent squatting motions or
overuse of joint
Joint/Bone instability: muscle
and/or joint and bone weakness

•

Genetic predisposition

•

Bone deformities

•

•

•

Osteoarthritis is simply explained
by the degeneration of the
protective cartilage in the joint that
cushions the end of bones
(“Osteoarthritis,” 2021)
OA is characterized by cartilage
erosion, synovial inflammation, and
subchondral sclerosis with
osteophyte formation (Yunus et al.,
2020)
OA is often referred to as the “wear
and tear disease” (“Osteoarthritis,”
2021)
Early changes are seen in the
region of articular cartilage surface
that carries the heaviest workload
(Yunus et al., 2020)

Significance of
Pathophysiology
Understanding the underlying
pathophysiology for OA, including the

OA further progresses, bone
changes with osteophyte
formations and bone cysts (Yunus
et al., 2020)

Symptomatic OA presents with
synovial inflammation and
hypertrophy contributing to the
progression of pain (Yunus et al.,
2020)
•
OA is now considered a disease
of the whole joint; recent
studies have shown pain is
associated with
alterations of peripheral and
central nerve sensitization,
bone marrow lesions and
synovitis as well (O’Neill
& Felson, 2018)

Left: An example of Kellgren-Lawrence
(Jang et al., 2021) (KL) OA grading scale of knee joint.
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It has been hypothesized that
vitamin D deficiency is associated
with a higher risk of development
of OA (Vina & Kwoh, 2018)

Two cohort studies included in
Vina & Kwoh (2018) noted the
significance of higher total dietary
fiber intake in relation to less knee
pain associated with OA
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Patients should be educated early
on about many preventative
measures that could help reduce the
effects of OA, including:

Conclusion
OA is a multifactorial, chronic,
degenerative joint disorder that should
be managed with preventative measures
and symptomatic treatment. Patients

Vitamin D plays a key role in
cartilage and bone metabolism
(Vina & Kwoh, 2018)
In a case study referenced in Vina
& Kwoh (2018) vitamin D3
supplementation did not reduce
joint space narrowing; however,
after 2 years, effusion synovitis
remained stable in OA patients
receiving vitamin D3 and had
progressively increased in the
placebo group
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Implications for
Nursing Care

IYNCJINil. M[-

Vitamin D/Dietary Fiber

Slrong-tion

(Jang et al., 2021)
Above: Recommended management of Osteoarthritis from three societies
Abbreviations: OARSI, Osteoarthritis Research Society International; ACR, American
College of Rheumatology; AAOS, American Academy of Orthopedic Surgeons,
NSAIDs, non-steroidal anti-inflammatory drugs
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frequent use and high stress load it carries for the body (Jang et al., 2021).
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synovial joint in the human body and is at the highest risk for OA development due to its

patient’s life. OA is commonly

Chondrocytes proliferate rapidly
when losing matrix and many
become hypertrophic (Yunus et al.,
2020)
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Osteoarthritis (OA) affects an estimated 240 million people worldwide, with

inflammation process, is a necessary

Cartilage is a unique tissue that is
made up of extracellular matrix
that consists of primarily collagen
and proteoglycans (“Osteoarthritis:
Pathophysiology,” 2019)

As OA progresses, increased
degradation and matrix loss due to
cytokines, proteases and
chondrocyte apoptosis (Yunus et
al., 2020)

“The future depends on what you do
today.” -Mahatma Gandhi
Introduction

Testing & Diagnosis
•

•

•
•
•
•
•

Upon assessment and diagnosis, it is
important to gather full patient history
and thorough physical exam (Katz et al,
2021)
There is no single lab or diagnostic test
to diagnose OA, the primary goal is to
differentiate between OA and other
forms of arthritis (Katz et al., 2021)

Physical assessment:
Decreased range of joint motion
Crepitus
AM stiffness and pain that improves
within 30 minutes of waking
Patient complaint of bony joint
enlargement
Joint swelling, tenderness, redness

•

•

•

•

•

Weight loss and weight
management programs

•

Structured exercise programs that
focus on strengthening upper and
lower extremity muscles, this leads
to improved pain and function (Katz
et al., 2021)

(Belleza, 2021)

Symptoms of OA and pathological
features can present despite normal
radiographic images (Katz et al., 2021)
Diagnosis:
X-ray imaging: will not show cartilage
changes, but can show joint space
narrowing and osteophytes
(“Osteoarthritis,” 2021)
MRI imaging: seldom indicated, but
maybe used to rule out fractures,
tumor, or infection (Katz et al., 2021)
Lab testing: Synovial fluid analysis
and blood tests that rule out other
causes of pain, such as rheumatoid
arthritis or infection (“Osteoarthritis,”
2021)

should be educated early on about the
importance of body movement, strength
training programs, healthy nutrition,
weight management, and vitamin
supplementation to slow the progression
of OA, especially in patients with a

•

Referral to physical and
occupational therapy programs can
improve muscle weakness and
limitations in joint range of motion
(Katz et al., 2021)

familial history. A variety of treatment
options, from NSAIDs to
viscosupplementation injections, are
available and research is ever-evolving to

•

Setting realistic expectations for
pain management is an important
factor. Overall, it has been argued in
many studies that opioids do not
demonstrate any advantage over
nonopioid treatment (Krebs et al.,
2018)

cellular therapy and gene therapy
treatment. The goal is to manage the
effects of OA and optimize quality of life
for all patients.
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